Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/21/2003WO2003021256A8 Method for identifying polymorphic markers in a population
08/21/2003WO2003020914A3 Protein phosphatase stress-related polypeptides and methods of use in plants
08/21/2003WO2003020895A3 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003018814A3 Enzymes involved in the triacylglycerol biosynthesis in the cytosol of eukaryotes
08/21/2003WO2003018760A3 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
08/21/2003WO2003018620A3 Serine protease inhibitor and processes for the preparation thereof
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003016565A3 Dna sequence analysis
08/21/2003WO2003016504A3 Polymorphisms associated with ion-channel disease
08/21/2003WO2003016474A3 Methods and compositions for use in selectively producing a protein in telomerase expressing cells
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003011220A3 Animal model for fatty acid amide-related neurobehaviors
08/21/2003WO2003008539A3 Non-alloying core shell nanoparticles
08/21/2003WO2003004665A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
08/21/2003WO2003002751A3 Alteration of oil traits in plants
08/21/2003WO2003002719A3 Isoform of castor oleate hydroxylase
08/21/2003WO2003002609A3 Dual-specific ligand and its use
08/21/2003WO2003000718A3 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome
08/21/2003WO2002101054A3 Process for the preparation of d-pantothenic acid and/or salts thereof
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002095027A3 Immunostimulatory oligodeoxynucleic molecules
08/21/2003WO2002094995A3 Methods and compositions using genetic package display
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002086125A3 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
08/21/2003WO2002083901A3 Plant growth regulating genes, proteins and uses thereof
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002081692A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003WO2002079398A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2002077236A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002077210A3 Methods to culture circovirus
08/21/2003WO2002074810A3 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
08/21/2003WO2002072140A3 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro
08/21/2003WO2002070695A3 Tumor associated proteins
08/21/2003WO2002068650A3 Modified and stabilized gdf propeptides and uses thereof
08/21/2003WO2002068473A8 Biosensor for detecting chemical agents
08/21/2003WO2002067861A3 Oncolytic adenoviral vectors
08/21/2003WO2002064776A3 Signal transduction proteins 15b3, 15b3-1 and 15b3-2, and related dna sequences
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002062999A3 Proteins and nucleic acids encoding same
08/21/2003WO2002061102A3 Control of gene expression in plants
08/21/2003WO2002061101A3 Method of imparting disease resistance to plants by reducing polyphenol oxidase activity
08/21/2003WO2002061090A3 Prokaryotically produced antibodies and uses thereof
08/21/2003WO2002060467A3 Compositions and methods for improving kidney function
08/21/2003WO2002057452A3 Human proteins, polynucleotides encoding them and methods of using the same
08/21/2003WO2002057418A3 Methods of producing polyketide synthase mutants and compositions and uses thereof
08/21/2003WO2002055660A3 A positive selection vector system for direct pcr cloning
08/21/2003WO2002051238A3 Recombinant dna vectors for expression of somatotropins
08/21/2003WO2002050545A3 Compositions and methods involving staphylococcus aureus protein staau-r9
08/21/2003WO2002048405A3 Non-invasive method for detecting target rna
08/21/2003WO2002048399A3 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna
08/21/2003WO2002046449A3 Selection of catalytic nucleic acids targeted to infectious agents
08/21/2003WO2002046416A3 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
08/21/2003WO2002046224A3 Compositions and methods relating to lung specific genes and proteins
08/21/2003WO2002044418A3 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
08/21/2003WO2002044209A3 Cytonkine receptor zcytor19
08/21/2003WO2002042467A8 Aspergillus fumigatus profilin
08/21/2003WO2002041833A3 Carotenoid biosynthesis
08/21/2003WO2002040535A3 Compositions and methods relating to ovary specific genes and proteins
08/21/2003WO2002037398A3 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens
08/21/2003WO2002036611A3 Immunomodulatory peptides derived from heat shock proteins and uses thereof
08/21/2003WO2002035240A3 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
08/21/2003WO2002033128A3 Multiplex quantification of nucleic acids in diseased cells
08/21/2003WO2002032925A3 Protein scaffolds for antibody mimics and other binding proteins
08/21/2003WO2002029083A3 Industrial-scale serum-free production of recombinant proteins in mammalian cells
08/21/2003WO2002029041A3 32146 and 57259, novel human transporters and uses thereof
08/21/2003WO2002022890A3 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample
08/21/2003WO2002022882A3 Target activated nucleic acid biosensor and methods of using same
08/21/2003WO2002022879A3 Detection of microsatellite instability and its use in diagnosis of tumors
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002012284A3 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
08/21/2003WO2002010433A3 Method and device for detecting bacterial contamination
08/21/2003WO2002010392A9 Mammalian dna binding membrane-associated protein-encoding gene and uses
08/21/2003WO2002010358A3 Nucleotide incorporating enzymes
08/21/2003WO2002006445A3 Transgenic mice containing targeted gene disruptions
08/21/2003WO2002006302A3 16816 and 16839, novel human phospholipase c molecules and uses therefor
08/21/2003WO2002004022A3 High fidelity polymerases and uses thereof
08/21/2003WO2002000717A3 Novel co-stimulatory molecules
08/21/2003WO2001094630A3 Compositions and methods for array-based nucleic acid hybridization
08/21/2003WO2001092581A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
08/21/2003WO2001090342A3 Genetic engineering of vascular grafts to resist disease
08/21/2003WO2001085792A3 Mu-1, member of the cytokine receptor family
08/21/2003WO2001079479A3 Methods for selective targeting
08/21/2003US20030159185 Replication protein A and use
08/21/2003US20030159184 Novel methods and constructs for plant transformation
08/21/2003US20030159183 Heterologous gene expression in plants
08/21/2003US20030159182 Production of therapeutic proteins in transgenic cereal crops
08/21/2003US20030159181 Method for influencing pollen development by modifying sucrose metabolism
08/21/2003US20030159180 Methods for altering organ mass in plants
08/21/2003US20030159179 Genetic engineered transgenic plant; controlling,germination
08/21/2003US20030159178 For transgenic plants; wound healing agents; surgical adhesives
08/21/2003US20030159177 Polynucleotides encoding polypeptides having invertase activity and use of same
08/21/2003US20030159175 Palm oil; genetic engineering
08/21/2003US20030159174 Genetic engineered plants
08/21/2003US20030159173 Gene expression; transgenic plant; generating fatty acid by elongation
08/21/2003US20030159171 Novel plant genes and uses thereof
08/21/2003US20030159169 Cell culture system and methods of use
1 ... 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 ... 4023